XGN - Financial Reports List - Exagen Inc. - IntrinsicAlpha

Exagen Inc. XGN

Healthcare - Medical - Diagnostics & Research - NASDAQ - US

$ 4.85

-1.34 %

$ 86.8 M

Market Cap

-5.34

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	-0.80%	32.51%	34.27%
Annual Report	FY	10-K	2024-12-31	5.89%	36.19%	40.29%
Quarterly Report	Q3	8-K	2024-09-30	-6.78%	7.15%	8.01%
Quarterly Report	Q2	8-K	2024-06-30	6.56%	40.83%	47.37%
Quarterly Report	Q1	8-K	2024-03-31	28.36%	56.30%	61.03%
Quarterly Report	Q4	8-K	2023-12-31	7.23%	61.17%	42.72%
Annual Report	FY	10-K	2023-12-31	15.33%	50.01%	43.67%
Quarterly Report	Q3	8-K	2023-09-30	-8.90%	-128.96%	35.15%
Quarterly Report	Q2	8-K	2023-06-30	57.74%	63.96%	61.32%
Quarterly Report	Q1	8-K	2023-03-31	8.04%	29.24%	20.38%

1